Evidence map›Paper›PMID 31548896›Full record

ReviewBMJ open respiratory research2019

Anaemia and iron dysregulation: untapped therapeutic targets in chronic lung disease?

Mehul S Patel, Elizabeth McKie, Michael C Steiner, Steven J Pascoe, Michael I Polkey

Open access · goldAbstract readReview
In one paragraph

Review in BMJ open respiratory research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Iron, Hepcidin, and Immunity.Advances in experimental medicine and biology · 2025
    Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Mehul S PatelR&D, GlaxoSmithKline, Stevenage, UK.ORCID 0000-0003-0435-858X
Elizabeth McKieR&D, GlaxoSmithKline, Stevenage, UK.
Michael C SteinerLeicester Biomedical Research Centre - Respiratory, Institute for Lung Health, University of Leicester, Leicester, UK.ORCID 0000-0002-0127-0614
Steven J Pascoe *Sanofi, Bridgewater, New Jersey, USA.
Michael I Polkey *National Heart and Lung Institute, Imperial College London, London, UK.
GlaxoSmithKline (United Kingdom) · GBImperial College London · GBSanofi (United States) · USUniversity of Leicester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypoxia is common in many chronic lung diseases. Beyond pulmonary considerations, delivery of oxygen (O

Indexed as

AnemiaChronic DiseaseHumansHypoxiaIron Metabolism DisordersLung DiseasesCOPD ÀÜ MechanismsSystemic disease and lungs

Identifiers

PMID31548896
PMCPMC6733331
OpenAlexW2970604410

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.